Breast reconstruction choice — options, timing under radiotherapy, implant versus DIEP trade-offs, nipple safety and BREAST-Q

Examiner prompts with model answers

Choice — no universal winner, checklist decides. Implants versus autologous flaps split the field, and 35 non-randomised studies with 57,555 participants leave no superior technique for all women — decide through preferences, breast characteristics, imaging, comorbidities, smoking, prior irradiation and planned adjuvants.^[1]

Timing and recurrence — horizons equal, early prices differ. Fifty-five studies with 14,217 patients show delayed autologous similar locoregional recurrence to immediate, with oncologic concerns not a reason to withhold timing or technique — offer every technically eligible option and let radiotherapy and patient factors set timing.^[3]

PMRT penalty — autologous tolerates radiation, implants fail more. Eleven studies with 1105 patients show PMRT multiplies morbidity with a detrimental effect on outcome, and 204 irradiated patients show expander/implant higher reoperation and failure than autologous in both immediate and delayed settings — counsel autologous first when PMRT is likely.^[13][14]

Implant trade-offs — DTI with ADM in numbers. One hundred fifty-four patients with 232 breasts carry 34% total complications with hematoma 4%, seroma 8%, infection 9% and wound problems 19%, plus 13% explantation with 6% implant loss — while 11-study meta-analysis shows ADM raising overall complications, infection and hematoma/seroma without moving explantation.^[7][9]

DIEP bilateral risk — consent doubles and more. Five hundred sixty-five flaps in 468 women show bilateral reconstructions twice as likely to need reoperation, with both unilateral and bilateral safe yet bilateral carrying higher complications and total flap loss — warn the risk-reducing bilateral patient explicitly.^[11]

Nipple safety — margin absolute, recurrence low, wounds real. Skin-sparing and nipple-sparing outcomes match non-conservative mastectomy with NAC recurrence 0-3.7%, yet a positive margin absolutely contraindicates preservation — select tumours without nipple involvement with mandatory margin assessment and counsel tobacco and radiation wound risk.^[17]

Outcomes that matter — BREAST-Q favours flaps at 2 years. Two thousand thirteen women with 1490 implant plus 523 autologous reconstructions across 11 centres show greater breast satisfaction and psychosocial and sexual well-being with autologous at 2 years — measure success by her BREAST-Q, not your photograph.^[20]